Smartphone-based Intervention for Young Adults With ADHD

Conditions: Attention Deficit/Hyperactivity Disorder(ADHD); Alcohol Use

Interventions: Device: Ecological Momentary Assessment for ADHD and Substance Use – Intervention Group; Device: Ecological Momentary Assessment for ADHD & Substance Use – Control Group

Sponsors: Traci Kennedy; National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With th

Conditions: Autism Spectrum Disorders

Interventions: Drug: Arbaclofen; Other: Placebo

Sponsors: Hospital General Universitario Gregorio Marañon; Fundación para la Investigación Biomédica del Hospital Gregorio Maranon

Recruiting

Efficacy and Mechanism of IPSRT for Bipolar II Disorder

Conditions: Bipolar Disorder II

Interventions: Drug: Quetiapine (drug); Behavioral: Psychopharmacological treatment

Sponsors: First Affiliated Hospital of Zhejiang University; Second Xiangya Hospital of Central South University; Brain Hospital Affiliated to Guangzhou Medical University; First Affiliated Hospital of Kunming Medical University; Brain Hospital Hunan Province; Hunan Mental Hospital; The Affiliated Hospital of Hangzhou Normal University; Zhejiang Provincial Tongde Hospital; Shanghai Mental Health Center

Not yet recruiting

Using Artificial Intelligence to Detect Early Signs of Alzheimer’s Disease in People With Memory Concerns

Conditions: Subjective Cognitive Decline; Alzheimer Disease; Mild Cognitive Impairment; Cognitive Decline

Interventions: Device: High-frequency Transcranial Magnetic Stimulation (TMS); Behavioral: Digital Cognitive Training; Behavioral: Structured Physical Exercise; Other: Management of Modifiable Vascular and Behavioral Risk Factors

Sponsors: IRCCS San Raffaele

Not yet recruiting